Core Scientific Balance Sheet Health
Financial Health criteria checks 2/6
Core Scientific has a total shareholder equity of $-418.7M and total debt of $850.3M, which brings its debt-to-equity ratio to -203.1%. Its total assets and total liabilities are $705.5M and $1.1B respectively.
Key information
-203.1%
Debt to equity ratio
US$850.32m
Debt
Interest coverage ratio | n/a |
Cash | US$42.15m |
Equity | -US$418.73m |
Total liabilities | US$1.12b |
Total assets | US$705.46m |
Recent financial health updates
Recent updates
Core Scientific: A Solid Bitcoin Mining Play
Oct 11Core Scientific: A Buy On Leading Bitcoin Production Numbers
Aug 11Core Scientific July bitcoin production rose 10.4% M/M with new deployments and multiple facilities
Aug 05Core Scientific signs $100M in committed equity facility for enhancing liquidity
Jul 21Why I'm Very Optimistic On Core Scientific's Future
Jun 10Robust Earnings May Not Tell The Whole Story For Core Scientific (NASDAQ:CORZ)
Apr 10Financial Position Analysis
Short Term Liabilities: CORZ.Q has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: CORZ.Q has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: CORZ.Q has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: CORZ.Q's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable CORZ.Q has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: CORZ.Q is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 11.1% per year.